在最新电话会议中,西氏医药服务公司高管指出,若要推动公司年同比增长率达到10%,GLP-1类药物的市场渗透率必须突破30%的关键阈值。这一表态凸显了新型代谢疗法对医疗供应链企业的业绩拉动作用,也反映出制药行业技术变革对上下游产业的深远影响。
在最新电话会议中,西氏医药服务公司高管指出,若要推动公司年同比增长率达到10%,GLP-1类药物的市场渗透率必须突破30%的关键阈值。这一表态凸显了新型代谢疗法对医疗供应链企业的业绩拉动作用,也反映出制药行业技术变革对上下游产业的深远影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.